Skip to main content
Top
Published in: Endocrine 3/2020

Open Access 01-06-2020 | Thyroidectomy | Original Article

Time trend analysis of thyroid cancer surgery in China: single institutional database analysis of 15,000 patients

Authors: Chengqiu Sui, Nan Liang, Rui Du, Qiao He, Daqi Zhang, Fang Li, Yantao Fu, Gianlorenzo Dionigi, Hui Sun

Published in: Endocrine | Issue 3/2020

Login to get access

Abstract

Purpose

The institutional database of the Thyroid Surgery Division in China–Japan Union Hospital of Jilin University was queried to audit time trend patterns in thyroid cancer (TC) management between 2008 and 2017.

Methods

Retrospective longitudinal analysis. Clinicopathological features and treatment strategies were analyzed. Frequencies and multivariate tests were used to detect correlations.

Results

Clinical data were obtained from 15,000 TC patients (i.e., 71.3% of 21,044 operations). Papillary was the most common histological subtype (n = 14,916, 99%), and 76% were microcarcinomas. Stage I (95%) and low-risk patients (58%) were prevalent throughout the 10-year period. The trend for total thyroidectomy increased from 29.1% (2008–2012) to 67.9% (2013–2015), and then dropped to 48.6% (2016–2017). A total of 8827 (52%) patients received central lymph node dissection (CLND). The tendency for CLND increased from 15.7 to 86.4% during the 10-year period. While the trend of lateral lymph node dissection decreased from 71.3 to 13.3%. Radioactive iodine therapy was offered to 10% of patients (2008–2012), except for a low value (5.4%) in 2009, and then increased from 12.3% (2012) to 41.3% (2015), while decreased to 32.4% (2017).

Conclusion

The surgical management of TC patients has undergone continuous changes over the past 10 years. The evolution from aggressive treatment to a more conservative approach has been constant. Our results suggest that the current surgical management approach for TC is adequate and in support of the published guidelines. Our findings warrant further investigation to determine the clinical implications of decision making for TC.
Appendix
Available only for authorised users
Literature
1.
go back to reference L. Du, R. Li, M. Ge, Y. Wang, H. Li, W. Chen, J. He, Incidence and mortality of thyroid cancer in China, 2008–2012. Chin. J. Cancer Res. 31(1), 144–151 (2019)CrossRef L. Du, R. Li, M. Ge, Y. Wang, H. Li, W. Chen, J. He, Incidence and mortality of thyroid cancer in China, 2008–2012. Chin. J. Cancer Res. 31(1), 144–151 (2019)CrossRef
2.
go back to reference L. Zhao, P. Pang, L. Zang, Y. Luo, F. Wang, G. Yang, J. Du, X. Wang, Z. Lyu, J. Dou, Y. Mu, Features and trends of thyroid cancer in patients with thyroidectomies in Beijing, China between 1994 and 2015: a retrospective study. BMJ Open 9(1), e023334 (2019)CrossRef L. Zhao, P. Pang, L. Zang, Y. Luo, F. Wang, G. Yang, J. Du, X. Wang, Z. Lyu, J. Dou, Y. Mu, Features and trends of thyroid cancer in patients with thyroidectomies in Beijing, China between 1994 and 2015: a retrospective study. BMJ Open 9(1), e023334 (2019)CrossRef
3.
go back to reference M. Huang, C. Yan, H. Wei, Y. Lv, R. Ling, Clinicopathological characteristics and prognosis of thyroid cancer in northwest China: a population-based retrospective study of 2490 patients. Thorac. Cancer 9(11), 1453–1460 (2018)CrossRef M. Huang, C. Yan, H. Wei, Y. Lv, R. Ling, Clinicopathological characteristics and prognosis of thyroid cancer in northwest China: a population-based retrospective study of 2490 patients. Thorac. Cancer 9(11), 1453–1460 (2018)CrossRef
4.
go back to reference C. Zhu, S. Li, X. Gao, G. Zhu, M. Song, F. Gao, Retrospective analysis of thyroid nodules: thyroid cancer risk factors in Suzhou, China. Clin. Lab. 64(3), 333–338 (2018)PubMed C. Zhu, S. Li, X. Gao, G. Zhu, M. Song, F. Gao, Retrospective analysis of thyroid nodules: thyroid cancer risk factors in Suzhou, China. Clin. Lab. 64(3), 333–338 (2018)PubMed
5.
go back to reference S. Liu, L. Yang, Y. Yuan, H. Li, J. Tian, S. Lu, N. Wang, J. Ji, Cancer incidence in Beijing, 2014. Chin. J. Cancer Res. 30(1), 13–20 (2018)CrossRef S. Liu, L. Yang, Y. Yuan, H. Li, J. Tian, S. Lu, N. Wang, J. Ji, Cancer incidence in Beijing, 2014. Chin. J. Cancer Res. 30(1), 13–20 (2018)CrossRef
6.
go back to reference L. Du, Y. Wang, X. Sun, H. Li, X. Geng, M. Ge, Y. Zhu, Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China. BMC Cancer 18(1), 291 (2018)CrossRef L. Du, Y. Wang, X. Sun, H. Li, X. Geng, M. Ge, Y. Zhu, Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China. BMC Cancer 18(1), 291 (2018)CrossRef
7.
go back to reference W.Q. Chen, H. Li, K.X. Sun, R.S. Zheng, S.W. Zhang, H.M. Zeng, X.N. Zou, X.Y. Gu, J. He, [Report of cancer incidence and mortality in China, 2014]. Zhonghua Zhong Liu Za Zhi 40(1), 5–13 (2018)PubMed W.Q. Chen, H. Li, K.X. Sun, R.S. Zheng, S.W. Zhang, H.M. Zeng, X.N. Zou, X.Y. Gu, J. He, [Report of cancer incidence and mortality in China, 2014]. Zhonghua Zhong Liu Za Zhi 40(1), 5–13 (2018)PubMed
8.
go back to reference H.X. Yan, P. Pang, F.L. Wang, W. Tian, Y.K. Luo, W. Huang, G.Q. Yang, N. Jin, L. Zang, J. Du, J.M. Ba, J.T. Dou, Y.M. Mu, Z.H. Lyu, Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study. Sci. Rep. 7(1), 15832 (2017)CrossRef H.X. Yan, P. Pang, F.L. Wang, W. Tian, Y.K. Luo, W. Huang, G.Q. Yang, N. Jin, L. Zang, J. Du, J.M. Ba, J.T. Dou, Y.M. Mu, Z.H. Lyu, Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study. Sci. Rep. 7(1), 15832 (2017)CrossRef
9.
go back to reference L. Yang, R.S. Zheng, N. Wang, H.M. Zeng, Y.N. Yuan, S.W. Zhang, H.C. Li, S. Liu, W.Q. Chen, J. He, [Analysis of incidence and mortality of thyroid cancer in China, 2013]. Zhonghua Zhong Liu Za Zhi 39(11), 862–867 (2017)PubMed L. Yang, R.S. Zheng, N. Wang, H.M. Zeng, Y.N. Yuan, S.W. Zhang, H.C. Li, S. Liu, W.Q. Chen, J. He, [Analysis of incidence and mortality of thyroid cancer in China, 2013]. Zhonghua Zhong Liu Za Zhi 39(11), 862–867 (2017)PubMed
10.
go back to reference X. Fei, Z. Lou, G. Christakos, Q. Liu, Y. Ren, J. Wu, Contribution of industrial density and socioeconomic status to the spatial distribution of thyroid cancer risk in Hangzhou, China. Sci. Total Environ. 613–614, 679–686 (2018)CrossRef X. Fei, Z. Lou, G. Christakos, Q. Liu, Y. Ren, J. Wu, Contribution of industrial density and socioeconomic status to the spatial distribution of thyroid cancer risk in Hangzhou, China. Sci. Total Environ. 613–614, 679–686 (2018)CrossRef
11.
go back to reference B.R. Shah, R. Griffiths, S.F. Hall, Thyroid cancer incidence among Asian immigrants to Ontario, Canada: a population-based cohort study. Cancer 123(17), 3320–3325 (2017)CrossRef B.R. Shah, R. Griffiths, S.F. Hall, Thyroid cancer incidence among Asian immigrants to Ontario, Canada: a population-based cohort study. Cancer 123(17), 3320–3325 (2017)CrossRef
12.
go back to reference F. Xiang, F. Huang, Y.Y. Zhang, Y.Q. Shao, N. Wang, Q.W. Jiang, [Trend in incidence of thyroid cancer in Jiading district of Shanghai, 2003–2013]. Zhonghua Yu Fang Yi Xue Za Zhi 50(7), 656–658 (2016) F. Xiang, F. Huang, Y.Y. Zhang, Y.Q. Shao, N. Wang, Q.W. Jiang, [Trend in incidence of thyroid cancer in Jiading district of Shanghai, 2003–2013]. Zhonghua Yu Fang Yi Xue Za Zhi 50(7), 656–658 (2016)
13.
go back to reference K. Li, G. Lin, Q. Zhou, X. Wu, [Time trends of the incidence of thyroid cancer in urban Guangzhou, 2000–2011]. Zhonghua Yu Fang Yi Xue Za Zhi 49(2), 142–146 (2015)PubMed K. Li, G. Lin, Q. Zhou, X. Wu, [Time trends of the incidence of thyroid cancer in urban Guangzhou, 2000–2011]. Zhonghua Yu Fang Yi Xue Za Zhi 49(2), 142–146 (2015)PubMed
14.
go back to reference L. Yang, R. Zheng, N. Wang, S. Zhang, W. Chen, [Analysis of incidence and mortality of thyroid cancer in China, 2010]. Zhonghua Yu Fang. Yi Xue Za Zhi 48(8), 663–668 (2014)PubMed L. Yang, R. Zheng, N. Wang, S. Zhang, W. Chen, [Analysis of incidence and mortality of thyroid cancer in China, 2010]. Zhonghua Yu Fang. Yi Xue Za Zhi 48(8), 663–668 (2014)PubMed
15.
go back to reference K. Song, L. Du, H. Li, X. Wang, W. Mao, C. Yu, [Incidence and mortality of thyroid cancer in six cancer registries of Zhejiang province, 2000-2009]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49(6), 493–496 (2014)PubMed K. Song, L. Du, H. Li, X. Wang, W. Mao, C. Yu, [Incidence and mortality of thyroid cancer in six cancer registries of Zhejiang province, 2000-2009]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49(6), 493–496 (2014)PubMed
16.
go back to reference L.B. Du, H.Z. Li, X.H. Wang, C. Zhu, Q.M. Liu, Q.L. Li, X.Q. Li, Y.Z. Shen, X.P. Zhang, J.W. Ying, C.D. Yu, W.M. Mao, Analysis of cancer incidence in Zhejiang cancer registry in China during 2000 to 2009. Asian Pac. J. Cancer Prev. 15(14), 5839–5843 (2014)CrossRef L.B. Du, H.Z. Li, X.H. Wang, C. Zhu, Q.M. Liu, Q.L. Li, X.Q. Li, Y.Z. Shen, X.P. Zhang, J.W. Ying, C.D. Yu, W.M. Mao, Analysis of cancer incidence in Zhejiang cancer registry in China during 2000 to 2009. Asian Pac. J. Cancer Prev. 15(14), 5839–5843 (2014)CrossRef
17.
go back to reference Y.Q. Liu, S.Q. Zhang, W.Q. Chen, L.L. Chen, S.W. Zhang, X.D. Zhang, R.S. Zheng, [Trend of incidence and mortality on thyroid cancer in China during 2003–2007]. Zhonghua Liu Xing Bing Xue Za Zhi 33(10), 1044–1048 (2012)PubMed Y.Q. Liu, S.Q. Zhang, W.Q. Chen, L.L. Chen, S.W. Zhang, X.D. Zhang, R.S. Zheng, [Trend of incidence and mortality on thyroid cancer in China during 2003–2007]. Zhonghua Liu Xing Bing Xue Za Zhi 33(10), 1044–1048 (2012)PubMed
18.
go back to reference Y. Wang, W. Wang, Increasing incidence of thyroid cancer in Shanghai, China, 1983–2007. Asia Pac. J. Public Health 27(2), NP223–229 (2015)CrossRef Y. Wang, W. Wang, Increasing incidence of thyroid cancer in Shanghai, China, 1983–2007. Asia Pac. J. Public Health 27(2), NP223–229 (2015)CrossRef
19.
go back to reference J. Xiang, Y. Wu, D.S. Li, Q. Shen, Z.Y. Wang, T.Q. Sun, Y. An, Q. Guan, New clinical features of thyroid cancer in eastern China. J. Visc. Surg. 147(1), e53–e56 (2010)CrossRef J. Xiang, Y. Wu, D.S. Li, Q. Shen, Z.Y. Wang, T.Q. Sun, Y. An, Q. Guan, New clinical features of thyroid cancer in eastern China. J. Visc. Surg. 147(1), e53–e56 (2010)CrossRef
20.
go back to reference S.Z. Cong, C.W. Huang, Z.W. Feng, [Interpreted American College of Radiology TI-RADS classification system of ultrasonography for thyroid nodules in 2017 edition and the experiences in clinical application]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 54(1), 73–77 (2019)PubMed S.Z. Cong, C.W. Huang, Z.W. Feng, [Interpreted American College of Radiology TI-RADS classification system of ultrasonography for thyroid nodules in 2017 edition and the experiences in clinical application]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 54(1), 73–77 (2019)PubMed
21.
go back to reference X.Y. Li, B. Zhang, Y.S. Lin, [The interpretation of 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 52(4), 309–315 (2017)PubMed X.Y. Li, B. Zhang, Y.S. Lin, [The interpretation of 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 52(4), 309–315 (2017)PubMed
22.
go back to reference X.B. Lan, H. Zhang, [An introduction of surgical update in 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer]. Zhonghua Wai Ke Za Zhi 54(3), 172–176 (2016)PubMed X.B. Lan, H. Zhang, [An introduction of surgical update in 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer]. Zhonghua Wai Ke Za Zhi 54(3), 172–176 (2016)PubMed
23.
go back to reference Chinese Medical Association Endocrinology Branch, Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Chin. J. Clinical Oncol. 39(17), 1249–1272 (2012) Chinese Medical Association Endocrinology Branch, Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Chin. J. Clinical Oncol. 39(17), 1249–1272 (2012)
24.
go back to reference M. Ya, [Interpretation of the management guidelines for patients with thyroid nodules and differentiated thyroid cancer (2012 Chinese edition)]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 27(16), 917–920 (2013)PubMed M. Ya, [Interpretation of the management guidelines for patients with thyroid nodules and differentiated thyroid cancer (2012 Chinese edition)]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 27(16), 917–920 (2013)PubMed
25.
go back to reference R.A. Agha, M.R. Borrelli, M. Vella-Baldacchino, R. Thavayogan, D.P. Orgill, S. Group, The STROCSS statement: strengthening the reporting of cohort studies in surgery. Int J. Surg. 46, 198–202 (2017)CrossRef R.A. Agha, M.R. Borrelli, M. Vella-Baldacchino, R. Thavayogan, D.P. Orgill, S. Group, The STROCSS statement: strengthening the reporting of cohort studies in surgery. Int J. Surg. 46, 198–202 (2017)CrossRef
26.
go back to reference B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)CrossRef B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)CrossRef
27.
go back to reference M.B. Amin, F.L. Greene, S.B. Edge, C.C. Compton, J.E. Gershenwald, R.K. Brookland, L. Meyer, D.M. Gress, D.R. Byrd, D.P. Winchester, The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin. 67(2), 93–99 (2017)CrossRef M.B. Amin, F.L. Greene, S.B. Edge, C.C. Compton, J.E. Gershenwald, R.K. Brookland, L. Meyer, D.M. Gress, D.R. Byrd, D.P. Winchester, The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin. 67(2), 93–99 (2017)CrossRef
28.
go back to reference R.D. Bliss, P.G. Gauger, L.W. Delbridge, Surgeon’s approach to the thyroid gland: surgical anatomy and the importance of technique. World J. Surg. 24(8), 891–897 (2000)CrossRef R.D. Bliss, P.G. Gauger, L.W. Delbridge, Surgeon’s approach to the thyroid gland: surgical anatomy and the importance of technique. World J. Surg. 24(8), 891–897 (2000)CrossRef
29.
go back to reference American Thyroid Association Guidelines Taskforce on Thyroid Nodules, Differentiated Thyroid Cancer, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009)CrossRef American Thyroid Association Guidelines Taskforce on Thyroid Nodules, Differentiated Thyroid Cancer, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009)CrossRef
30.
go back to reference G. Dionigi, F. Frattini, Staged thyroidectomy: time to consider intraoperative neuromonitoring as standard of care. Thyroid 23(7), 906–908 (2013)CrossRef G. Dionigi, F. Frattini, Staged thyroidectomy: time to consider intraoperative neuromonitoring as standard of care. Thyroid 23(7), 906–908 (2013)CrossRef
31.
go back to reference F.N. Tessler, W.D. Middleton, E.G. Grant, J.K. Hoang, L.L. Berland, S.A. Teefey, J.J. Cronan, M.D. Beland, T.S. Desser, M.C. Frates, L.W. Hammers, U.M. Hamper, J.E. Langer, C.C. Reading, L.M. Scoutt, A.T. Stavros, ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J. Am. Coll. Radiol. 14(5), 587–595 (2017)CrossRef F.N. Tessler, W.D. Middleton, E.G. Grant, J.K. Hoang, L.L. Berland, S.A. Teefey, J.J. Cronan, M.D. Beland, T.S. Desser, M.C. Frates, L.W. Hammers, U.M. Hamper, J.E. Langer, C.C. Reading, L.M. Scoutt, A.T. Stavros, ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J. Am. Coll. Radiol. 14(5), 587–595 (2017)CrossRef
32.
go back to reference X. Wang, X. Wei, Y. Xu, H. Wang, X. Xin, S. Zhang, [Ultrasonic characteristics of thyroid nodules and diagnostic value of thyroid imaging reporting and data system (TI-RADS) in the ultrosound evaluation of thyroid nodules]. Zhonghua Zhong Liu Za Zhi 37(2), 138–142 (2015)PubMed X. Wang, X. Wei, Y. Xu, H. Wang, X. Xin, S. Zhang, [Ultrasonic characteristics of thyroid nodules and diagnostic value of thyroid imaging reporting and data system (TI-RADS) in the ultrosound evaluation of thyroid nodules]. Zhonghua Zhong Liu Za Zhi 37(2), 138–142 (2015)PubMed
33.
go back to reference J.H. An, H.Y. Kim, S.G. Kim, H. Dralle, G.W. Randolph, E. Piantanida, M.L. Tanda, G. Dionigi, Endpoints for screening thyroid cancer in the Republic of Korea: thyroid specialists’ perspectives. J. Endocrinol. Invest. 40(6), 683–685 (2017)CrossRef J.H. An, H.Y. Kim, S.G. Kim, H. Dralle, G.W. Randolph, E. Piantanida, M.L. Tanda, G. Dionigi, Endpoints for screening thyroid cancer in the Republic of Korea: thyroid specialists’ perspectives. J. Endocrinol. Invest. 40(6), 683–685 (2017)CrossRef
34.
go back to reference D. Zhang, J. Zhang, G. Dionigi, F. Li, T. Wang, H. Li, N. Liang, H. Sun, Recurrent laryngeal nerve morbidity: lessons from endoscopic via bilateral areola and open thyroidectomy technique. World J. Surg. 43, 2829–2841 (2019)CrossRef D. Zhang, J. Zhang, G. Dionigi, F. Li, T. Wang, H. Li, N. Liang, H. Sun, Recurrent laryngeal nerve morbidity: lessons from endoscopic via bilateral areola and open thyroidectomy technique. World J. Surg. 43, 2829–2841 (2019)CrossRef
35.
go back to reference G.G. Callender, T. Carling, E. Christison-Lagay, R. Udelsman, Surgery for thyroid cancer. Endocrinol. Metab. Clin. North Am. 43(2), 443–458 (2014)CrossRef G.G. Callender, T. Carling, E. Christison-Lagay, R. Udelsman, Surgery for thyroid cancer. Endocrinol. Metab. Clin. North Am. 43(2), 443–458 (2014)CrossRef
36.
go back to reference J. Liang, Z. Li, F. Fang, T. Yu, S. Li, Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature. ACTA Otorhinolaryngol. Ital. 37(1), 1–8 (2017)PubMedPubMedCentral J. Liang, Z. Li, F. Fang, T. Yu, S. Li, Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature. ACTA Otorhinolaryngol. Ital. 37(1), 1–8 (2017)PubMedPubMedCentral
37.
go back to reference X. Liu, D. Zhang, G. Zhang, L. Zhao, L. Zhou, Y. Fu, S. Li, Y. Zhao, C. Li, C.W. Wu, F.Y. Chiang, G. Dionigi, H. Sun, Laryngeal nerve morbidity in 1.273 central node dissections for thyroid cancer. Surg. Oncol. 27(2), A21–A25 (2018)CrossRef X. Liu, D. Zhang, G. Zhang, L. Zhao, L. Zhou, Y. Fu, S. Li, Y. Zhao, C. Li, C.W. Wu, F.Y. Chiang, G. Dionigi, H. Sun, Laryngeal nerve morbidity in 1.273 central node dissections for thyroid cancer. Surg. Oncol. 27(2), A21–A25 (2018)CrossRef
38.
go back to reference H.N. Cho, E. Choi, D.H. Seo, B. Park, S. Park, J. Cho, S. Kim, Y.R. Park, Y. Rhee, K.S. Choi, Determinants of undergoing thyroid cancer screening in Korean women: a cross-sectional analysis from the K-Stori 2016. BMJ Open 9(4), e026366 (2019)CrossRef H.N. Cho, E. Choi, D.H. Seo, B. Park, S. Park, J. Cho, S. Kim, Y.R. Park, Y. Rhee, K.S. Choi, Determinants of undergoing thyroid cancer screening in Korean women: a cross-sectional analysis from the K-Stori 2016. BMJ Open 9(4), e026366 (2019)CrossRef
39.
go back to reference Y.K. So, M.J. Kim, S. Kim, Y.I. Son, Lateral lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis for prevalence, risk factors, and location. Int J. Surg. 50, 94–103 (2018)CrossRef Y.K. So, M.J. Kim, S. Kim, Y.I. Son, Lateral lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis for prevalence, risk factors, and location. Int J. Surg. 50, 94–103 (2018)CrossRef
40.
go back to reference S. Vaccarella, L. Dal Maso, M. Laversanne, F. Bray, M. Plummer, S. Franceschi, The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid 25(10), 1127–1136 (2015)CrossRef S. Vaccarella, L. Dal Maso, M. Laversanne, F. Bray, M. Plummer, S. Franceschi, The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid 25(10), 1127–1136 (2015)CrossRef
41.
go back to reference D.V.P. Araque, A. Bleyer, J.P. Brito, Thyroid cancer in adolescents and young adults. Future Oncol. 13(14), 1253–1261 (2017)CrossRef D.V.P. Araque, A. Bleyer, J.P. Brito, Thyroid cancer in adolescents and young adults. Future Oncol. 13(14), 1253–1261 (2017)CrossRef
Metadata
Title
Time trend analysis of thyroid cancer surgery in China: single institutional database analysis of 15,000 patients
Authors
Chengqiu Sui
Nan Liang
Rui Du
Qiao He
Daqi Zhang
Fang Li
Yantao Fu
Gianlorenzo Dionigi
Hui Sun
Publication date
01-06-2020
Publisher
Springer US
Published in
Endocrine / Issue 3/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02230-7

Other articles of this Issue 3/2020

Endocrine 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.